Marco Bressers
About
In The Last Decade
Marco Bressers
16 papers receiving 853 citations
Peers
Comparison fields: 5 of 53
- Surgery 797
- Cardiology and Cardiovascular Medicine 597
- Radiology, Nuclear Medicine and Imaging 391
- Pulmonary and Respiratory Medicine 274
- Biomedical Engineering 35
Countries citing papers authored by Marco Bressers
This map shows the geographic impact of Marco Bressers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Bressers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Bressers more than expected).
Fields of papers citing papers by Marco Bressers
This network shows the impact of papers produced by Marco Bressers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Bressers. The network helps show where Marco Bressers may publish in the future.
Co-authorship network of co-authors of Marco Bressers
This figure shows the co-authorship network connecting the top 25 collaborators of Marco Bressers. A scholar is included among the top collaborators of Marco Bressers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Bressers. Marco Bressers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 114 | |
| 2 | 59 | |
| 3 | 65 | |
| 4 | 7 | |
| 5 | 34 | |
| 6 | 10 | |
| 7 | 83 | |
| 8 | Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial. | 81 |
| 9 | 4 | |
| 10 | 51 | |
| 11 | Virtual histology and remodelling index allow in vivo identification of allegedly high-risk coronary plaques in patients with acute coronary syndromes: a three vessel intravascular ultrasound radiofrequency data analysis. | 22 |
| 12 | One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-I. | 18 |
| 13 | 132 | |
| 14 | One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES). | 19 |
| 15 | Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. | 122 |
| 16 | 66 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.